Arca
Skip to content
Tools
Tools

Atrial flutter

Drug research and approvals for atrial flutter: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 32 studies of atrial flutter are recruiting on ClinicalTrials.gov, Health Canada has authorized 3 drug trials for it since 2013, and FDA has 1 approved and 0 open orphan designations naming it.

  • Recruiting worldwide: 32
  • Trials authorized in Canada: 3
  • FDA orphan approvals: 1
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 32 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

2 approved, 8 in phase 3, 5 in phase 2; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Dofetilide, Landiolol

Dronedarone
Phase 3 Voltage-gated L-type calcium channel blocker
Tedisamil
Phase 3 Voltage-gated potassium channel blocker
Amiodarone
Phase 3 HERG blocker
Vernakalant
Phase 3 Kir3.1/Kir3.4 blocker
Ramipril
Phase 3 Angiotensin-converting enzyme inhibitor
Warfarin
Phase 3 Vitamin k epoxide reductase complex subunit 1 isoform 1 inhibitor
Apixaban
Phase 3 Coagulation factor X inhibitor
Ascorbic acid
Phase 3 Supplement
Celivarone
Phase 2 Unknown
Onabotulinumtoxina
Phase 2 Synaptosomal nerve-associated protein 25 (SNAP-25) inhibitor
Betrixaban
Phase 2 Coagulation factor X inhibitor
AZD1305
Phase 2 HERG blocker
Vanoxerine
Phase 2

How Its Trials Ended

192 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 47 whose ending is known, 51% met their primary endpoint, 11% missed it and 38% stopped early.

  • Completed, result not reported7841%
  • Ongoing4322%
  • Met its primary endpoint2413%
  • Status unknown2413%
  • Stopped: other or unclear116%
  • Missed its primary endpoint53%
  • Stopped: enrollment or feasibility21%
  • Stopped: sponsor or business decision21%
  • Stopped: lack of efficacy11%
  • Stopped: safety11%
  • Stopped: funding11%

Trials Authorized in Canada

Newest first; search them all in Canada trials
Aug 12, 2014Genetic-af - a genotype-directed comparative effectiveness trial of bucindolol and and toprol-xl for prevention of symptomatic atrial fibrillation/atrial…bucindolol/ metoprololArca Biopharma IncClosed
Jul 18, 2014Rate control versus rhythm control for postoperative atrial fibrillationAmiodaroneInternational Center For Health Outcomes And Innovation ResearchOngoing
Sep 6, 2013Fast (fetal atrial flutter & supraventricular tachycardia) therapy trial - substudy aDigoxin / sotalolHospital For Sick ChildrenPending

FDA Orphan Designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Jul 2, 2009So-AqueousFor use as a substitute for oral sotalol in patients who are unable to take sotalol orally [oral sotalol is indicated for maintenance of…AltaThera Pharmaceuticals LLCApproved

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.